INSTITUT NATIONAL DE RECHERCHE ET DE SECURITE POUR LA PREVENTION DES ACCIDENTS DU TRAVAIL ET DES MALADIES PROFESSIONNELLES ASSOCIATION

Their core work

INRS is France's national institute for occupational health and safety research, mandated to study and prevent workplace accidents and occupational diseases. Their scientific work centers on assessing chemical and physical hazards in the workplace — measuring exposure, identifying biomarkers of harm, and translating findings into policy-usable reference values. In H2020, they contributed specialist expertise in nanotoxicology (assessing risks from engineered nanomaterials) and human biomonitoring (measuring the actual body burden of chemical exposures in working populations). They function as a bridge between laboratory science and regulatory practice, producing data that informs occupational exposure limits and health guidelines.

What they specialise in

How they've shifted over time

INRS's two H2020 projects span 2016–2022 and show a progression from narrow nanomaterial hazard tools toward broad population-level chemical surveillance. Their earlier engagement (SmartNanoTox, 2016) focused on the specific technical challenge of assessing risk from engineered nanomaterials — a targeted, laboratory-oriented task. Their later involvement (HBM4EU, 2017) moved upstream toward cohort-level human biomonitoring, reference value setting, and connecting scientific data to policy decisions across chemical mixtures and endocrine disruptors. The trajectory is clear: from single-hazard technical tools toward systems-level chemical health surveillance with direct regulatory application.

INRS is moving toward large-scale population health monitoring and the translation of chemical exposure data into occupational and regulatory policy, making them an increasingly valuable partner for projects that need to connect lab science with real-world health standards.

How they like to work

INRS has not coordinated any H2020 projects — they join exclusively as participant or third party, functioning as a specialist contributor that brings institutional expertise rather than administrative leadership. Their network of 124 unique partners across 30 countries suggests they are drawn into large, multi-stakeholder European initiatives rather than small bilateral collaborations. This pattern is consistent with their status as a national institute: they provide validated occupational health data and methodology to consortia that need a recognized reference body.

INRS has built a network of 124 unique consortium partners across 30 countries through just two projects, indicating that both SmartNanoTox and HBM4EU were large, pan-European initiatives with broad multi-country participation. Their reach is genuinely European in scope, with no indication of a narrow geographic cluster.

What sets them apart

INRS occupies a rare institutional niche as France's sole national body dedicated entirely to occupational health and safety research — a government-backed association with a statutory mandate to produce reference data for workplace hazard regulation. Unlike university research groups, INRS produces results that directly feed French and European occupational exposure standards, giving their data immediate policy weight. For consortium builders who need a credible, nationally recognized occupational health authority to validate exposure data or provide regulatory translation, INRS is one of a very small number of organizations in Europe that can credibly fill that role.

Highlights from their portfolio

• SmartNanoTox
  INRS's only directly funded H2020 project (EUR 799,328), focused on developing predictive tools for nanomaterial hazard assessment — a high-priority regulatory gap area in occupational and consumer safety.
• HBM4EU
  One of the largest EU human biomonitoring programs ever run, HBM4EU produced harmonized reference values for chemical exposures across Europe; INRS's third-party role signals their recognized expertise in occupational biomonitoring methodology.